Ablatus Therapeutics

info@ablatus.co.uk

Contact Us

You can contact us by email info@ablatus.co.uk

Click here to ensure you receive the latest updates from Ablatus

Click here to learn more about BETA

Our technology, Bimodal Electric Tissue Ablation (BETA) is next-generation radiofrequency ablation offering larger, more effective ablations with potentially fewer adverse events and at lower cost than RFA.

5 Feb
Ablatus secures £500,000 in private finance deal

Our recent work with Innovate UK EDGE innovation and growth specialist Emma… | Read more
5 Feb
Ablatus shortlisted for coveted #21toWatch Awards

The 2021 shortlist for the coveted #21toWatch Awards was revealed earlier this… | Read more
28 Jan
David Lewis joins Ablatus as CEO

We are delighted to announce the appointment of David Lewis as CEO… | Read more
25 Aug
Ablatus awarded £1M Innovate UK grant

We are delighted to have been awarded over £1M by the UK… | Read more
7 Feb
Ablatus Therapeutics receives first CE Mark for Bimodal Electric Tissue Ablation system component

We are delighted to announce that we have received our first CE… | Read more